Fig. 8

Schematic diagram of PLGA based biomaterials for tumor immunotherapy. A Schematic illustration of the (a) preparation process and (b) action step of DNCaNPs for effective cancer chemo- & immunotherapy. B In vivo antitumor efficacy of the DNCaNP-mediated chemo- & immunotherapy on orthotopic 4T1 tumor models. (a) The therapeutic schedule. (b) Tumor growth curve and (c) corresponding survival curves of these 4T1 tumors with various treatments. (d) TUNEL and H&E staining of tumor slices collected from the mice with various treatments at day 7. (Reproduced with permission from [96] Copyright © 2020, Nano-Micro Letters)